Literature DB >> 28838845

Inflammation fires up cancer metastasis.

Bin-Zhi Qian1.   

Abstract

Metastatic disease is the major challenge of cancer that accounts for over 90% of total cancer lethality. Mounting clinical and preclinical data now indicate that inflammation, a potent immune and repair response, is indispensable for metastasis. In this review we describe our current understanding of how major inflammatory cells contribute to metastatic cascade with a focus on the primary tumour. We also discuss exciting new directions for future research and novel therapeutic approaches to tackle metastatic disease through targeting inflammation.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Immunology; Inflammation; Metastasis

Mesh:

Year:  2017        PMID: 28838845     DOI: 10.1016/j.semcancer.2017.08.006

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  25 in total

Review 1.  Liver metastases.

Authors:  Diamantis I Tsilimigras; Pnina Brodt; Pierre-Alain Clavien; Ruth J Muschel; Michael I D'Angelica; Itaru Endo; Rowan W Parks; Majella Doyle; Eduardo de Santibañes; Timothy M Pawlik
Journal:  Nat Rev Dis Primers       Date:  2021-04-15       Impact factor: 52.329

2.  Role of IL-17RA in the proliferative priming of hepatocytes in liver regeneration.

Authors:  Danilo Piobbico; Daniela Bartoli; Stefania Pieroni; Antonella De Luca; Marilena Castelli; Luigina Romani; Giuseppe Servillo; Maria Agnese Della-Fazia
Journal:  Cell Cycle       Date:  2018-11-11       Impact factor: 4.534

3.  C-reactive protein and tumour diagnosis predict survival in patients treated surgically for long bone metastases.

Authors:  Costantino Errani; Monica Cosentino; Giovanni Ciani; Lorenzo Ferra; Patricio A Alfaro; Barbara Bordini; Davide M Donati
Journal:  Int Orthop       Date:  2021-01-04       Impact factor: 3.075

4.  miR-155 overexpression is followed by downregulation of its target gene, NFE2L2, and altered pattern of VEGFA expression in the liver of melanoma B16-bearing mice at the premetastatic stage.

Authors:  Mariya B Aksenenko; Nadezhda V Palkina; Olga N Sergeeva; Ekaterina Yu Sergeeva; Andrey K Kirichenko; Tatiana G Ruksha
Journal:  Int J Exp Pathol       Date:  2020-02-11       Impact factor: 1.925

Review 5.  Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies.

Authors:  Josh W DiGiacomo; Daniele M Gilkes
Journal:  Target Oncol       Date:  2018-04       Impact factor: 4.493

6.  Prognostic value of C-reactive protein levels in patients with bone neoplasms: A meta-analysis.

Authors:  Wenyi Li; Xujun Luo; Zhongyue Liu; Yanqiao Chen; Zhihong Li
Journal:  PLoS One       Date:  2018-04-18       Impact factor: 3.240

7.  Dynamic Changes in the Neutrophil-to-Lymphocyte Ratio Predict the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.

Authors:  Hongyu Wang; Chuyang Lin; Wenzhe Fan; Jiang Zhang; Yingqiang Zhang; Wang Yao; Jiaping Li
Journal:  Cancer Manag Res       Date:  2020-05-14       Impact factor: 3.989

8.  Prognostic value of preoperative inflammation-based predictors in patients with bladder carcinoma after radical cystectomy.

Authors:  Huiming Gui; Yutong Song; Yongsheng Yin; Hanzhang Wang; Ronald Rodriguez; Zhiping Wang
Journal:  Open Med (Wars)       Date:  2021-05-21

9.  A novel robust nomogram based on peripheral monocyte counts for predicting lymph node metastasis of prostate cancer.

Authors:  Jia-Wei Zhou; Yun-Hua Mao; Yang Liu; Hai-Tao Liang; Chandni Chandur Samtani; Yue-Wu Fu; Yun-Lin Ye; Gang Xiao; Zi-Ke Qin; Cun-Dong Liu; Jian-Kun Yang; Qi-Zhao Zhou; Wen-Bin Guo; Kang-Yi Xue; Shan-Chao Zhao; Ming-Kun Chen
Journal:  Asian J Androl       Date:  2021 Jul-Aug       Impact factor: 3.285

Review 10.  Plant-Derived Anticancer Agents: Lessons from the Pharmacology of Geniposide and Its Aglycone, Genipin.

Authors:  Solomon Habtemariam; Giovanni Lentini
Journal:  Biomedicines       Date:  2018-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.